TY - JOUR T1 - Illustrating Emerging Good Practices for Quantitative Benefit-Risk Assessment: A Hypothetical Case Study of Systemic Biologic Treatments for Plaque Psoriasis JO - Value in Health UR - http://dx.doi.org/10.1016/j.jval.2023.01.018 PY - 2023/02/09 AU - Lackey LG AU - Ng X AU - Veldwijk J AU - Thokala P AU - Levitan B AU - Payne K AU - Ho M AU - Tervonen T ED - DO - DOI: 10.1016/j.jval.2023.01.018 PB - Elsevier BV VL - 26 IS - 4 SP - 519 EP - 527 Y2 - 2025/04/09 ER -